Figure 2From: Breast cancer in women using digoxin: tumor characteristics and relapse riskEstimated relapse hazard ratio (95% CI) for digoxin-exposed compared to unexposed (referent) women with breast cancer, adjusting for current age group and stratifying by protocol, protocol year, histological grade, node status, tumor size, and estrogen receptor status.Back to article page